Results 231 to 240 of about 59,004 (282)
Some of the next articles are maybe not open access.
Journal of American Academy of Dermatology, 2020
BACKGROUND There is an increased incidence of malignancy in patients with dermatomyositis. It is unknown if the risk differs between the subtypes of dermatomyositis.
Kimberly Bowerman +3 more
semanticscholar +1 more source
BACKGROUND There is an increased incidence of malignancy in patients with dermatomyositis. It is unknown if the risk differs between the subtypes of dermatomyositis.
Kimberly Bowerman +3 more
semanticscholar +1 more source
Melanoma research, 2020
Checkpoint inhibitor immunotherapy is a transformative treatment for advanced malignancies, but can be associated with numerous immune-related adverse events (irAEs).
C. Kosche +4 more
semanticscholar +1 more source
Checkpoint inhibitor immunotherapy is a transformative treatment for advanced malignancies, but can be associated with numerous immune-related adverse events (irAEs).
C. Kosche +4 more
semanticscholar +1 more source
EJD. European journal of dermatology, 2019
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody has been recognized to be significantly associated with a subset of dermatomyositis patients with rapidly progressive interstitial lung disease (RP-ILD).
S. Motegi +12 more
semanticscholar +1 more source
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody has been recognized to be significantly associated with a subset of dermatomyositis patients with rapidly progressive interstitial lung disease (RP-ILD).
S. Motegi +12 more
semanticscholar +1 more source
Seminars in Cutaneous Medicine and Surgery, 2001
Dermatomyositis is a disease that has a characteristic skin eruption that may occur with or without a proximal myopathy. The disease with cutaneous features only is classified as amyopathic dermatomyositis. The origin is unknown, but autoimmune factors are believed to play an important role.
openaire +2 more sources
Dermatomyositis is a disease that has a characteristic skin eruption that may occur with or without a proximal myopathy. The disease with cutaneous features only is classified as amyopathic dermatomyositis. The origin is unknown, but autoimmune factors are believed to play an important role.
openaire +2 more sources
Zeitschrift für Rheumatologie, 2006
Juvenile dermatomyositis (JDM) is an inflammatory multi-system disease of unknown etiology with classic involvement of the skin and striated muscles. Following a prodromal period, patients develop a progressive proximal muscle weakness. Typical skin involvement includes heliotrope rash, facial erythema, Gottron's sign and nailfold capillary ...
F, Dressler, H-I, Huppertz
openaire +2 more sources
Juvenile dermatomyositis (JDM) is an inflammatory multi-system disease of unknown etiology with classic involvement of the skin and striated muscles. Following a prodromal period, patients develop a progressive proximal muscle weakness. Typical skin involvement includes heliotrope rash, facial erythema, Gottron's sign and nailfold capillary ...
F, Dressler, H-I, Huppertz
openaire +2 more sources
Interstitial Lung Disease in Polymyositis and Dermatomyositis.
Clinics in Chest Medicine, 2019The idiopathic inflammatory myopathies (IIMs), including polymyositis (PM) and dermatomyositis (DM), are autoimmune connective tissue diseases with variable degrees of muscle inflammation and systemic involvement.
K. Long, S. Danoff
semanticscholar +1 more source
The Indian Journal of Pediatrics, 1996
The clinical profile of 7 children and their follow-up is described. There was female preponderance with mate to female ratio of 1:6. The median age of onset was 6 years. All the patients had skin rash, muscle weakness and abnormal enzyme profile. Muscle biopsy was performed in 6 and was abnormal in all of them.
V, Seth +3 more
openaire +4 more sources
The clinical profile of 7 children and their follow-up is described. There was female preponderance with mate to female ratio of 1:6. The median age of onset was 6 years. All the patients had skin rash, muscle weakness and abnormal enzyme profile. Muscle biopsy was performed in 6 and was abnormal in all of them.
V, Seth +3 more
openaire +4 more sources
2013
Juvenile dermatomyositis (JDM) is a systemic, inflammatory, idiopathic disease, mainly affecting the skin and the muscles, starting before the age of 16, with an incidence around one case per 1 million children. Some patients display typical features of JDM without skin involvement, or even without muscle involvement; however, both tissues are affected
Pierre, Quartier, Romain K, Gherardi
openaire +2 more sources
Juvenile dermatomyositis (JDM) is a systemic, inflammatory, idiopathic disease, mainly affecting the skin and the muscles, starting before the age of 16, with an incidence around one case per 1 million children. Some patients display typical features of JDM without skin involvement, or even without muscle involvement; however, both tissues are affected
Pierre, Quartier, Romain K, Gherardi
openaire +2 more sources
Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
Clinical reviews in allergy and immunology, 2021Wanlong Wu +7 more
semanticscholar +1 more source
Rheumatic Disease Clinics of North America, 1991
Juvenile dermatomyositis is a relatively rare, multisystem disease characterized by a nonsuppurative myositis which causes symmetrical weakness, rash and vasculitis; this last can affect the gastrointestinal tract and the myocardium. Late development of calcinosis is seen in approximately two thirds of patients.
openaire +3 more sources
Juvenile dermatomyositis is a relatively rare, multisystem disease characterized by a nonsuppurative myositis which causes symmetrical weakness, rash and vasculitis; this last can affect the gastrointestinal tract and the myocardium. Late development of calcinosis is seen in approximately two thirds of patients.
openaire +3 more sources